secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elanco Animal Health Inc (ELAN)
CIK:        0001739104
Form:       8-K
Filed at:   2022-01-06T23:59:59+00:00
Accession:  0001104659-22-001914
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Elanco EVP Aaron Schacht departs Dec 31 to lead microbiome platform carve-out; service fee up to $750k
--------------------------------------------------------------------------------

- Aaron Schacht separated from Elanco on Dec 31, 2021 as part of restructuring plan announced Nov 30, 2021.
- Schacht will lead external team developing Microbiome Platform; Elanco to pay service fee up to $750k through Mar 31, 2022.
- Contingent fee may be paid upon consummation of carve-out transaction.
- Severance Agreement provides benefits under Elanco Executive Severance Pay Plan, contingent on release of claims.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1739104/000110465922001914/0001104659-22-001914-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1739104/000110465922001914/tm221865d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-001914

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer